| PERIOD ENDING | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | | Total Revenue | 613,100 | 919,100 | 878,800 | 760,000 | | Cost of Revenue | 21,600 | 447,700 | 661,600 | 276,300 | | | Gross Profit | 591,500 | 471,400 | 217,200 | 483,700 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 231,900 | 41,200 | (233,300) | 37,100 | | Non Recurring | 4,000 | 1,800 | 36,200 | (54,900) | | Others | 180,100 | 161,300 | 142,500 | 126,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 175,500 | 267,100 | 271,800 | 375,500 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (20,500) | (130,500) | (77,000) | (15,800) | | Earnings Before Interest And Taxes | 153,400 | 138,200 | 193,700 | 358,200 | | Interest Expense | 30,400 | 31,800 | 28,600 | 32,800 | | Income Before Tax | 123,000 | 106,400 | 165,100 | 325,400 | | Income Tax Expense | 44,500 | 38,700 | 43,900 | 121,200 | | Minority Interest |
-
|
-
| (2,100) | (2,400) | | | | Net Income From Continuing Ops | 78,500 | 67,700 | 121,200 | 204,200 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 78,500 | 67,700 | 121,200 | 204,200 | | Preferred Stock And Other Adjustments | (600) | (500) |
-
|
-
| | | Net Income Applicable To Common Shares | $77,900 | $67,200 | $121,200 | $204,200 |
|
0.03% Nasdaq 
0.32 (0.76%) 
Income Statement
